Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Claire’s Place Foundation Expands COVID-19 Programs to Support People with Cystic Fibrosis


“I feel this program is perhaps the best way to empower the CF community,” said Work Proudly Program Participant Derek. “I’ve never heard about a CF program like this. The team at Claire’s Place Foundation are trailblazers.”

Claire’s Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis (CF), is pleased to announce that its COVID-19 Emergency Fund and new Work Proudly Program have had a significant impact assisting the CF community through the pandemic and will expand in 2021. The fund provided essential needs to people with CF throughout the COVID-19 outbreak, while the Work Proudly Program is supporting the community long-term with job training and equipment needed for work-from-home employment.

“My daughter Claire certainly has been our angel as we endured this difficult year,” said Claire’s Place Foundation Executive Director Melissa Yeager. “As the most vulnerable to COVID-19, the CF Community needed us more than ever. I am so proud of our team and supporters that quickly jumped in at the onset of the pandemic to provide emergency funds to families with CF. Jobs rapidly evaporated, limiting the financial ability to purchase everything from cereal to copayments for medications. To date, we have helped 1,039 individuals, giving over $46,500 for daily essential needs. As quarantining prolonged, more and more individuals with CF and their families were impacted and lost their jobs. In response, we created the Work Proudly Program to provide certificate training and the equipment needed to gain and maintain meaningful, safe, remote employment for adults with CF and caregivers. The program has attracted an overwhelming amount of supporters, top grants and a waitlist of participants. We look forward to expanding it in 2021.”

In 2020, the Claire’s Place Foundation Work Proudly Program helped 15 people with CF and caregivers learn a trade that can be done from anywhere. They want to learn, they want to work, they want to be empowered, they just need the right training and tools to manage their job from home, the hospital or from wherever the wild CF ride takes them. “I feel this program is perhaps the best way to empower the CF community,” said Work Proudly Program Participant Derek. “I’ve never heard about a CF program like this. The team at Claire’s Place Foundation are trailblazers.”

“This year was unprecedented territory for us all and I know Claire is so proud of how her legacy, the Claire’s Place Foundation, has adapted to meet the short-term and long-term needs of people with CF due to this pandemic,” said Melissa. “We also recently gained another angel, our good friend, supporter and retired Zappos CEO Tony Hsieh. Tony supported us in many ways from giving Claire a stage and literally the jacket off his back, to funding our Hospital Playroom Program through Zappos for Good. We will miss him dearly and will carry on his mission of creating happiness with the opening of our second playroom at The Memorial Care Miller Children’s and Women’s Hospital in Long Beach, California, as soon as it is safe to do so. As we look to 2021, we are excited to celebrate our 10th anniversary and make it another impactful year, whatever the world throws at us!”

To assist Claire Place Foundation’s mission, please visit the website to make a tax-deductible donation. The Work Proudly Program is looking for supporters and is in critical need of laptops. To become a supporter of this program please visit here.

About Claire’s Place Foundation, Inc.

Claire’s Place Foundation, Inc. is a 501(c)(3) non-profit organization providing support to children and families affected by cystic fibrosis (CF). Claire’s Place Foundation is named in honor of Claire Wineland who lived with CF her entire life and passed away at the age of 21. Claire was an activist, author, TEDx Speaker, social media star and received numerous awards. Claire’s foundation was a way for her to assure that others living with CF enjoyed the same hope, strength and joy that she enjoyed. Recipient of Los Angeles Business Journal’s “Small Nonprofit of the Year,” the foundation provides grants to families affected by CF, offering both emotional and financial support. Today, Claire’s Place Foundation continues to carry on Claire’s legacy. For more information and make a donation, please visit http://www.clairesplacefoundation.org.

Share article on social media or email:

Capsa Healthcare Introduces Kidney Cart for Simple Computing Mobility in Any Care Facility


Simple, Lightweight Kidney Laptop Cart

Nurses can easily maneuver the Capsa Kidney Cart through hallways, in patient rooms, and around tight spaces

Capsa Healthcare announces the release of the new Kidney Cart, an ultra-lightweight documentation cart with ample workspace to mobilize electronic health records in any care facility.

Capsa’s Kidney Cart is an expansion of its non-powered line of computing cart solutions. This new product supports the healthcare market’s need for a light-duty, versatile and spacious workstation. The generous-sized ergonomic curved top accommodates virtually any laptop computer and is offered in four color options to coordinate with modern interiors.

Clinicians can easily maneuver the Kidney Cart through hallways, in patient rooms, and around tight spaces. The simple height adjustment (up to 48”h) accommodates sit-or-stand patient interaction and suits a variety of applications such as clinical documentation or patient registration. The simple, cost-effective platform can be deployed in any care setting including hospitals, surgery centers, physicians’ offices, assisted living facilities, and more.

About Capsa Healthcare

Capsa Healthcare is a worldwide leader in developing and delivering innovative healthcare solutions for a wide spectrum of care providers. With 50+ years of experience, Capsa Healthcare offers a unique ability to meet the demands of diverse healthcare environments and offers a broad range of products including medication carts, medical carts, point-of-care carts, and pharmacy automation solutions. Headquartered in Portland, OR, Capsa Healthcare has over 400 employees with management, sales, and production offices throughout the world. To learn more, visit http://www.capsahealthcare.com or call 800-437-6633.

Follow Capsa Healthcare on Facebook (https://www.facebook.com/capsahealthcare/), Twitter (https://twitter.com/CapsaHealthcare), and LinkedIn (https://www.linkedin.com/company/CapsaHealthcare). ###

Share article on social media or email:



Invisible People Releases Comprehensive New Look at Public Perception of Homelessness in America


What America Believes About Homelessness’

“More than three-quarters of the public believe homelessness has increased within their own community this year,” said Horvath. “The ongoing COVID-19 pandemic has intensified the urgency in solving the homelessness crisis in the U.S., as we face a growing wave of evictions and foreclosures.”

Invisible People, a nonprofit dedicated to educating the public about homelessness, released today a comprehensive report detailing public perceptions of homelessness in the U.S and messaging recommendations for advocates and policymakers. The report highlights the growing disconnect between public perceptions and the actual root causes that make a person vulnerable to losing their home – from unemployment to rising healthcare costs and a shortage of affordable housing.

In September 2020, Invisible People surveyed more than 2,500 U.S. residents in 16 cities to identify public attitudes about homelessness and measure support for common policy recommendations. Researchers studied how different audiences receive and interpret messages about homelessness. The report, What America Believes About Homelessness, also provides a toolkit for building public and political support designed for policymakers, advocates, service providers and others working to end homelessness.

“More than three-quarters of the public believe homelessness has increased within their own community this year,” said Mark Horvath, founder and CEO of Invisible People. “The ongoing COVID-19 pandemic has intensified the urgency in solving the homelessness crisis in the U.S., as we face a growing wave of evictions and foreclosures across the U.S.”

What America Believes About Homelessness highlights broad public support for humane policy solutions, including expanded mental health services (82%), permanent supportive housing (75%) and rental assistance programs (71%). While public perception on policy solutions aligns with the recommendations of experts in the sector, the study reveals a significant gap between the public conversation on homelessness and discussions happening in policy and research spaces. While experts point to a lack of income and the scarcity of affordable housing as central causes of homelessness, Invisible People’s report shows the public believes mental illness and addiction are the culprits.

“Driven by local news stories and what people see in their own communities, public perception centers on a few of the most visible negative consequences of homelessness,” said Horvath. “The visibility of addiction and mental illness play an outsized role in the public’s imagination. The resulting stigma drives negative perceptions of homeless people and opposition to housing projects. Addressing these concerns requires consistent messaging that humanizes homeless people, helping the public to shift from sympathy to empathy.”

What America Believes About Homelessness was created through a collaboration with partners Alter Agents, Opinion Route and Barbara Poppe and Associates. Barbara Poppe is the former executive director of the United States Interagency Council on Homelessness, where she led the launch of the first comprehensive federal strategic plan to prevent and end homelessness in 2010.

“This groundbreaking study will be incredibly useful for communities and organizations that are working to build public will to invest in solutions to reduce and ultimately end unsheltered homelessness,” said Barbara Poppe. “More than ever, we need to find ways to improve communication and understanding. This landmark report on public perceptions advances that important work.”

According to the report, people living in areas with higher unsheltered populations are more concerned about crime and experience greater feelings of helplessness. ‘Not in My Backyard’ opinions, opposing housing in one’s own neighborhood, are linked to opposition to housing solutions as well as more punitive views towards homeless people. In addition, gender and political views impact opinions on homelessness, with women and those on the left of the political spectrum expressing more sympathetic opinions. Men and those on the right express more punitive views. Just 32% of the public support criminalization measures, according to the report.

“We found that stories of individuals being housed and rebuilding their lives resonate with audiences. In contrast, messaging that portrays our current system as successful is not considered credible by the general public who see evidence of individual suffering on the streets,” said Mike Dickerson, researcher, co-founder of Ktown for All and author of What America Believes About Homelessness. “We recommend that advocates and policy makers avoid making big claims about systemic success, especially in communities where homelessness continues to rise.”

“There is a direct line between how the public views homelessness and the policy choices leaders make. Many blame homelessness on the person experiencing it rather than the shortage of affordable housing, lack of a living wage, childhood trauma, expensive and inaccessible health care, or the countless other reasons that make a person vulnerable to losing their home,” said Dickerson. “This gap between public perceptions and reality creates a cycle of misunderstanding that reduces public support for the policies we need to solve this crisis.”

Download the full report here.

About Invisible People

Invisible People is a 501(c)(3) nonprofit dedicated to educating the public about homelessness through innovative storytelling, news and advocacy. Since our launch in 2008, Invisible People has become a pioneer and trusted resource for inspiring action and raising awareness in support of advocacy, policy change and thoughtful dialogue around poverty in North America and the United Kingdom.

Media Contact:

Mark Horvath, info@invisiblepeople.tv, 213-245-1519

Share article on social media or email:

Renowned Beverly Hills Plastic Surgeon Dr. John Anastasatos Announces the Launch of his New State-Of-The-Art Website


News Image

I am thrilled to share our new website. It is a great resource to help patients stay informed and involved in the services and procedures we provide at Los Angeles Plastic Surgery, says Dr. Anastasatos.

John Anastasatos, M.D., FACS, is pleased to announce the launch of his brand-new practice website, http://www.LosAngelesPlasticSurgery.com. The user-friendly website displays Dr. Anastasatos’s elite qualifications and the services offered at Los Angeles Plastic Surgery for men and women wanting to explore enhancing their appearance. The innovative website provides high-resolution photos and informative content that accurately reflects Dr. Anastasatos’s expertise and artistic talent. It is easy to navigate and features an appealing layout that is tailored for the needs of both current and potential patients. The website design keeps patients fully educated on the treatment options available at the cutting-edge practice. Los Angeles Plastic Surgery offers a full menu of services to improve one’s appearance from head to toe, with gold-standard facelifts, advanced breast augmentations, body lift procedures and non-surgical treatments. Dr. Anastasatos is board certified by the American Board of Plastic Surgery and is widely known as one of the top professionals in his field. He has gained a reputation for his knowledge and ability to create incredible, natural-looking results in both cosmetic and reconstructive plastic surgery, including revision cosmetic surgery of the face, breast, body and nose. Whether it’s a small change or a full-body makeover, patients can expect exceptional cosmetic results with patient-centric care when they choose Los Angeles Plastic Surgery and the skilled hands of Dr. Anastasatos.

“I am thrilled to share our new website. It is a great resource to help patients stay informed and involved in the services and procedures we provide at Los Angeles Plastic Surgery,” says Dr. Anastasatos. Los Angeles Plastic Surgery is unique in that we offer the full spectrum of operative, non-surgical and injectable treatments for the face, nose, breast, and body.

More about Dr. John M. Anastasatos:

Dr. Anastasatos was born in New York City and he was raised in the United States, but his family roots are in Athens, Greece. Dr. Anastasatos earned his bachelor’s degree in economics from Brown University in only three years and was immediately accepted in their School of Medicine. General surgical training followed at Columbia-Presbyterian Hospital, an affiliate of Columbia University. Dr. Anastasatos then moved south to the University of Alabama, Birmingham (UAB) for his cosmetic and reconstructive residency. He also completed a fellowship in hand surgery, upper extremity and microsurgery. Upon the completion of his extensive training, he was appointed as an assistant professor of plastic surgery. During this time, Dr. Anastasatos also served as an attending surgeon at UAB Hospitals, The Children’s Hospital and Veterans Administration Hospital. He then moved to Southern California and established his own plastic surgery clinic in 2007 in Beverly Hills. As his practice and reputation grew, he opened a second location in Athens, Greece. Dr. Anastasatos has earned global recognition for his beautiful surgical results, treating international patients from all over the world.

Dr. Anastasatos is certified by the American Board of Plastic Surgery. He is an active member of the American Society of Plastic Surgery and the American Society of Aesthetic Plastic Surgeons. He servers as an expert reviewer for the Medical Board of California. He has been recognized by the United States Congress for his work in plastic surgery and charity.

To schedule a consultation with Dr. John Anastasatos or for more information about his practice locations in Beverly Hills, CA, or Athens, Greece, please call (310) 888-4048, or visit the new website at http://www.LosAngelesPlasticSurgery.com.

Share article on social media or email:

Dr. Sebi’s Cell Food Launches Redesigned Website, Logo, and Products


News Image

Dr. Sebi’s Cell Food has announced the launch of their new website, featuring a modern, streamlined aesthetic that includes a redesigned logo and product packaging.

The newly designed site, still found at http://www.drsebiscellfood.com, integrates Dr. Sebi’s Cell Food products and remedies with user friendly UI, mobile optimization, and a new earthy design. Along with their popular, natural dietary supplements, the brand now offers a new line of full spectrum hemp CBD products that includes drops, capsules, soft gels, pre-rolls, and a unique hemp and chamomile tea.

Dr. Sebi’s Cell Food was founded by Alfredo Bowman, better known as Dr. Sebi, in 2014, two years before the self-trained herbalist and naturalist passed away. The relaunch of the Dr. Sebi’s Cell Food website is part of the brand’s ongoing celebration of the 60th anniversary of their founder’s first foray into health and wellness.

The brand remains staunchly committed to the teachings of its founder, and will continue to highlight his holistic approach to health, nutrition, and wellness, popularly known as the “African Bio-Mineral Diet” — a nutritional framework designed by Dr. Sebi that focuses on rejuvenating cells by eliminating toxic waste through blood alkalization.

Dr. Sebi’s Cell Food provides dietary guidelines and natural plant-based supplements and teas that have earned a considerable following, with over 1 million Instagram followers and numerous high-profile fans, including actor-singer Serayah McNeill (Empire), tattoo artist Kat Von D, and beloved comedian Cedric the Entertainer. While making no medical claims, all of their products are natural, safe to use, and prepared in an FDA-certified facility.

About Dr. Sebi’s Cell Food

Dr. Sebi’s Cell Food is a distinguished producer of plant-based supplements for those seeking positive pathways to improving their lives. They offer natural botanical compounds based on the formulations of their founder, Dr. Sebi. He began creating natural plant-based compounds meant to cleanse and revitalize the cells. This led to the establishment of Dr. Sebi’s Cell Food, which has continued Dr. Sebi’s commitment to providing natural ways to help people live a better life. Subscribe to the Dr. Sebi newsletter at drsebiscellfood.com, or follow them on Instagram at @drsebiscellfood.

Share article on social media or email:



Scientists Unlock Promising Key to Preventing Cancer Relapse After Immunotherapy


Mount Sinai researchers have solved one of the enduring mysteries of cancer immunotherapy: Why does it completely eliminate tumors in many patients, even when not all the cells in those tumors have the molecular target that the therapy is aimed at?

The answer involves a protein called fas, and regulating fas may be a route to preventing cancer relapse, the researchers reported in a study published in Cancer Discovery in December.

Cancer immunotherapies target antigens, or proteins, on the surface of tumor cells. One common example is a protein called CD19. But even when most cells in a tumor express CD19 on their surface, some do not. And tumors are constantly evolving and often experience “antigen escape,” meaning that the target is no longer expressed, which can make the immunotherapy fail and the cancer relapse.

The researchers discovered that cancer immunotherapies that make use of immune system cells such as T cells and CAR-T cells kill not only tumor cells that express the drugs’ target, but also adjacent tumor cells that lack the targets, because of the presence of fas. This process, known as bystander killing, can be made more effective by adding therapeutics that turn off the regulation of fas proteins, the researchers said.

“This study should engender many clinical trials solving the common weakness of immunotherapies—antigen escape and relapse,” said Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai. “Specifically, by combining immunotherapies with small molecule inhibitors that increase fas-signaling, which are already being used in the clinic, bystander tumor cell killing may be potentiated and eliminate antigen-loss variants from heterogenous tumors.”

T cell-based immunotherapies—including CAR-T, bispecific antibodies, and anti-PD1 antibodies—have revolutionized cancer treatment. However, even with the remarkably high response rates of CAR-T-treated patients, most either progress or relapse within one year.

In this study, Mount Sinai researchers looked at tumors from patients in a large clinical trial studying CAR-T’s effectiveness in patients with non-Hodgkin’s lymphoma and found for the first time that the level of fas present in the tumors predicted the patients’ response to the drug and their long-term survival. Those with significantly elevated fas in their tumors had longer-lasting positive responses to the therapy.

Based on this, the researchers tested small-molecule therapies that increased the function of fas in the tumor cells, in turn increasing the targeted and bystander tumor cell killing induced by T cells, CAR-T cells, and bispecific antibodies.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

Disability Rights Ohio (DRO) Advocates for Rapid Inclusion of All Ohioans With Disabilities as State Develops Its COVID-19 Vaccination Plan


News Image

As the leading non-profit corporation focused on advocating for the human, civil and legal rights of people with disabilities in Ohio, Disability Rights Ohio (DRO) and its partners urge the Ohio Department of Health (ODH) to consider its recommendations as it formulates the state’s COVID-19 Vaccination Plan. While DRO and its partners is encouraged that Phase 1A of the present plan includes the people with intellectual disabilities, as well as those with mental illness, who live in group homes and the staff there, and patients and staff at psychiatric hospitals and residents and staff of nursing facilities and assisted living facilities and veteran homes, as well as hospital caregivers, it is not enough. A letter from DRO leadership and its partners to ODH Director Stephanie McCloud, recommends that the following should be incorporated into the Plan as well:


  • Prioritize people with disabilities in all types of congregate settings;
  • Prioritize people with disabilities, regardless of age, in all congregate settings;
  • Prioritize people with disabilities in home and community-based services settings;
  • Prioritize individuals with intellectual and developmental disabilities, even if they do not fit within one of the existing categories; and
  • Ensure that both the information and education about the administration of the vaccine are accessible to people with disabilities.

DRO and its partners strongly encourage the revision of Ohio’s interim draft plan to effectively address risks to individuals with disabilities who live in any type of congregate setting and include these individuals and staff who work in these congregate settings into Phase 1. Complying with public health guidelines, like social distancing, is difficult or impossible in any type of congregate setting, not just the facilities in Ohio’s current plan. Furthermore, people of all ages are at risk in these congregate settings, so there should not be age restrictions. And prisons, jails, and detention centers should also be a high priority, as the incarcerated population disproportionately includes people with disabilities, who often face a higher risk of complication or death from COVID-19.

People rely on aides or nurses for their care in home and community-based settings, too, so this makes it difficult or impossible to practice social distancing. And people with intellectual and developmental disabilities in general have been shown to be at much higher risk in experiencing serious complications form COVID-19 and should also be prioritized.

Finally, the state should commit to ensure that the benefits and possible risks and side effects of the vaccines are effectively and transparently communicated to people with disabilities so they can make decisions with informed consent. DRO and its partners’ letter can be read here.

DRO and its partners commend Ohio for its thoughtful approach in determining critical populations by placing first responders, high-risk healthcare workers, people at significantly higher risk due to comorbid or underlying conditions, and older adults living in congregate or overcrowded settings amongst the earliest to receive the vaccine. We also applaud the state for recognizing in its interim draft plan that racial and ethnic minority populations have a higher prevalence of comorbidities and risks of infection. As the number of COVID-19 cases continue to rise across our state, DRO and its partners are committed to working hand in hand with ODH to ensure all Ohioans are vaccinated as safely and quickly as possible.

Disability Rights Ohio is the federally and state designated Protection and Advocacy System and Client Assistance Program for the State of Ohio. The mission of Disability Rights Ohio is to advocate for the human, civil and legal rights of people with disabilities in Ohio. Disability Rights Ohio provides legal advocacy and rights protection to a wide range of people with disabilities. http://www.disabilityrightsohio.org

Partners that are included in the letter: Ohio Brain Injury Program, University of Cincinnati Center for Excellence in Developmental Disabilities, Ohio Olmstead Task Force, Down Syndrome Association of Central Ohio, Coalition for Community Living – Ohio, Disability Law Society at Case Western Reserve University, Ohio Chapter of the National Association of Social Workers and Columbus Chapter of the National Association of Black Social Workers.

Share article on social media or email:

Artificial Intelligence Technology Powers Award-Winning Clinical Research in Dentistry


“Dr. Hamdan’s research is an excellent example of university and business collaboration utilizing experts in radiology, deep learning and statistical analysis to produce clinically relevant and potentially game changing results validating software that can elevate patient care”. Dr. Don Tyndall UNC

Dentists can expect to be better than ever before in catching undiagnosed or overlooked conditions and identifying pathologies thanks to Denti.AI’s radiographic analysis, new clinical research shows.

The American Academy of Oral and Maxillofacial Radiology awarded the prestigious 2020 Albert G. Richards Graduate Student Research Award to a University of North Carolina Adams School of Dentistry graduate student who showed the artificial intelligence software often accurately identified pathoses missed by board-certified dental experts.

Manal Hamdan, DDS, conducted the study titled “Detecting Apical Radiolucencies Using Deep Learning Technology: A Pilot Study.” She concluded that Denti.AI’s technology had comparable or improved results, and the artificial intelligence tool has the potential to reduce provider fatigue and diagnostic errors. Her poster on the same research won first prize for the best scientific poster at the AAOMR annual session.

Dr. Don Tyndall, Professor of Oral and Maxillofacial Radiology at the Adams School of Dentistry stated, “Dr. Hamdan’s research is an excellent example of university and business collaboration utilizing experts in radiology, deep learning and statistical analysis to produce clinically relevant and potentially game changing results validating software that can elevate patient care.”

“Our team at Denti.AI is committed to being at the forefront of implementing artificial intelligence into clinical practices through rigorous academic validation and collaboration with leading academic institutions,” said Dmitry Tuzoff, founder and CEO of Denti.AI.

This is the second academic award the company’s product has received this year. The University of Louisville awarded first prize to a separate clinical study featuring Denti.AI’s technology.

“We are building technology to help support oral health providers by bringing clarity, standardization, quality assurance, efficiency, and trust to the dental marketplace,” said Eric Pulver, DDS, the Chief Dental Officer of Denti.AI.

With Denti.AI’s radiograph analysis, providers will catch more pathologies and help patients better understand the need for treatment to increase both quality of care and case acceptance. Denti.AI’s cloud-based software centralizes the clinical data into its analytics platform, which makes it easy to see business performance in relation to hard clinical data. Plus, its patent-pending auto-charting technology incorporates the radiographs directly into the clinical workflow which improves operational efficiency.

Thanks to the AI-powered medical imaging technology, dental practices gain profitability, speed and quality. With Denti.AI, it only takes several seconds to interpret a series of intraoral x-rays or a panoramic image and produce a complete dental chart. Based on the experience of professional radiologists who participated in the training of the algorithms, Denti.AI looks to find what the naked eye often cannot. You can see for yourself at Denti.AI.

Denti.AI (http://www.denti.ai) is a software company that leverages AI analysis of dental x-rays to detect key abnormalities, past dental treatments, and other relevant features to find problems earlier and improve productivity. Its cloud-based service is integrated with a range of practice management software and imaging equipment, automating the clinical workflow of dental support organizations across North America.

For more information, or to participate in a free trial, visit http://www.denti.ai

Reporters May Contact:

Jeff Durrbeck VP of Sales

jdurrbeck@denti.ai

Share article on social media or email:

Diamond Packaging Introduces Lockbox™ Certified Child-Resistant (CR) Packaging for Medical and Recreational Marijuana Products


The Diamond Lockbox™ designs are a synergy of creative structural design, beautiful aesthetics, and industry-leading sustainability practices that Diamond is known for.

Diamond Packaging today announced the introduction of its new Diamond Lockbox™ folding cartons, an upscale, certified child-resistant (CR) packaging solution for medical or recreational marijuana products. Diamond Lockbox™ folding cartons combine beauty with strength for the ultimate in cannabis packaging design. The single and dual lock options feature finished edges and ample billboard space and can be decorated with a wide range of printing and finishing effects.

Diamond’s award-winning team of design engineers and packaging experts developed Diamond Lockbox™ folding cartons for cannabis brands looking for a user friendly and compliant packaging option luxurious enough to rival that of high-end cosmetic brands.

“We are excited to introduce Diamond Lockbox™ as a natural evolution in cannabis packaging design,” said Dennis Bacchetta, director of marketing. “The Lockbox™ designs are a synergy of creative structural design, beautiful aesthetics, and industry-leading sustainability practices that Diamond is known for.”

The patent-pending designs were tested by a third party laboratory using the U.S. Consumer Product Safety Commission’s (CPSC) protocol and standards for Poison Prevention Packaging and fulfill the requirements of the Code of Federal Regulations (CFR) Title 16, Part 1700.20.

All Diamond Lockbox™ designs feature discreet child-resistant (CR) release mechanisms to ensure compliance for both child safety and senior adult use effectiveness (SAUE). The reclosable designs maintain CR functionality and produce a clicking sound for audible feedback. The cartons utilize laminated, tear-resistant paperboard outer cartons and paperboard inserts that can be customized to hold a wide range of products, including edibles, pre-rolled joints, vape cartridges, vape pens, and concentrates.

Diamond Lockbox™ cartons incorporate the company’s Green Chic™ packaging model, which delivers “Beauty without Compromise” by capturing the essence of luxury or upscale cannabis brands through more sustainable converting methods. Green Chic™ utilizes multiple in-line technologies – TruCOLOR™ expanded color gamut (ECG) printing, cold foiling, specialty coatings, Liquid Metal™ metallic UV coatings, and Cast and Cure holographic effects. All packaging is designed utilizing paperboard and manufactured using 100% clean, renewable wind energy in a Zero Waste to Landfill (ZWL) facility.

About Diamond Packaging:

Founded in 1911, Diamond Packaging is a WBENC-certified woman-owned business specializing in developing innovative and sustainable packaging solutions. Utilizing state of-the-art technologies, Diamond designs and manufactures folding cartons for the personal care (cosmetics, hair care, skin care, fragrance, oral care, and shaving), health care, pharmaceutical, cannabis, and consumer electronics industries. Its client portfolio includes Bausch + Lomb, Coty, Charlotte’s Web, Columbia Care, L’Oréal, Otter Products, Procter & Gamble, Revlon, Shiseido, and many other Fortune 500 companies. Diamond differentiates itself through award-winning creative design, packaging innovation/technical expertise, its greenbox sustainability initiative, and the Global Packaging Alliance® (GPA). For more information visit http://www.diamondpackaging.com, or follow Diamond on Facebook, Twitter, Instagram, and LinkedIn. For more information on Diamond Lockbox™ folding cartons visit http://www.diamondpackaging.com/lockbox.

Media Contact:

Dennis Bacchetta

Director of Marketing

dbacchetta@diamondpkg.com

(585) 334-8030 x229

Share article on social media or email:

Athena Therapeutics Announces Initial Financing From HighCape Capital And Connecticut Innovations


News Image

Athena Therapeutics today announced the closing of an initial financing round with HighCape Capital and Connecticut Innovations. This round of funding will provide the necessary resources to create an innovative cancer drug company that combines world-class scientists, powerful intellectual property, support from Yale University, and a leadership team with extensive experience building successful life sciences companies.

Utilizing discoveries and intellectual property licensed from Yale, Athena will focus on exploiting unique metabolic defects in cancer with the goal of developing transformative therapeutics to treat various forms of cancer.

Yale School of Medicine Professor and Athena Co-Founder Dr. Ranjit Bindra, M.D., PhD., said, “We now understand that cancer cells have numerous unique defects in nicotinamide adenine dinucleotide (NAD) metabolism, which are dependent on key driver mutations, tissue-of-origin, and epigenetic state. These defects are prime targets for small molecule inhibitors of NAD metabolism that could effectively treat a range of cancers, and Athena is laser-focused on exploring this emerging field of drug development.” City of Hope National Medical Center Professor and Chair of the Department of Diabetes & Cancer Metabolism, and Athena Co-Founder Dr. Charles Brenner, Ph.D., said, “Having worked on NAD metabolism for over 20 years, I am excited to translate key discoveries from the laboratory into the clinic that target key sensitivities in cancer metabolism.”

HighCape Capital Partner and Athena Co-Founder Kevin Rakin added, “There is a great unmet need for precision medicine approaches that are specifically focused on cancer metabolism, and Athena will fill this gap. This initial investment will allow the Company to expand its footprint and efforts in Connecticut with the goal of building a robust pre-clinical and clinical pipeline in oncology.”

About Athena Therapeutics:

Athena has developed cutting edge approaches to probe for, identify, and characterize altered states of NAD metabolism and flux. In parallel, it is generating new classes of small molecules which will target multiple nodes in NAD synthesis pathways.

To support these research efforts, the Company has recruited a team of researchers with critical expertise in NAD metabolism including Dr. Emmanuel Burgos, formerly of the Albert Einstein College of Medicine, to lead the internal discovery biology capabilities and establish a suite of NAD pathway targets for development. To complement internal expertise, Athena has assembled a Scientific Advisory Board of world experts, which includes Professor Vern Schramm of the Albert Einstein College of Medicine, a world renown enzymologist specializing in NAMPT and drug design, and Dr. Leonard Post, a seasoned oncology drug developer and discoverer of the PARP inhibitor talazoparib.

About the Science of NAD:

Nicotinamide adenine dinucleotide (NAD) is an essential co-factor required for a wide range of processes in mammalian cells, and multiple pathways have evolved to maintain adequate NAD levels for cellular survival. Research from Athena co-founders, Drs. Ranjit Bindra and Charles Brenner, established that cancer cells can have targetable defects in NAD synthesis, which can be exploited therapeutically. One set of discoveries in this area was published by the Bindra and Brenner laboratories recently in Nature Communications.

Key biomarkers associated with this discovery have been exclusively in-licensed from Yale University and the University of Iowa.

Share article on social media or email: